Artemis Medicare Services Limited has informed the Exchange that Board of Directors at its meeting held on May 08, 2026, recommended Final Dividend of Re. 0.45 per equity share.
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.1 pts more than Nifty Microcap 250 and 5.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Artemis Medicare Services reported strong FY26 standalone results with revenue from operations growing 16.1% to Rs 1,06,049 Lacs from Rs 91,326 Lacs in FY25. Net profit after tax rose 24% to Rs 10,344 Lacs from Rs 8,346 Lacs. EPS stood at Rs 6.55 vs Rs 5.42 in the prior year. The Board recommended a final dividend of Rs 0.45 per equity share (45% on Re. 1 face value), subject to shareholder approval at the AGM. An exceptional item of Rs 307.44 Lacs was recorded due to the impact of new Labour Codes on employee gratuity and leave liabilities. The company also appointed two new Independent Directors and reappointed T R Chadha & Co LLP as statutory auditors for a second 5-year term. Unutilized funds from a preferential issue have been extended by 18 months. The auditors issued an unmodified (clean) opinion on both standalone and consolidated results.
Strong 24% PAT growth and 16% revenue growth reflect healthy operational performance. The dividend payout is modest at 45 paise per share, suggesting retained earnings are being prioritized for growth. No audit qualifications are a positive sign for financial integrity.